The aim of this study was to investigate the CSF protein profile in a cohort of HTLV-1 AC and HAM/TSP patients with distinct rates of disease progression to discover biomarkers to improve the diagnosis of HAM/TSP. This evidence concerns the gene CSF2 and tropical spastic paraparesis.